Sameera R. Samarakoon

This study uses network pharmacology and molecular docking to explore Vernolac's anticancer mechanisms, identifying key phytochemicals and pathways involved in apoptosis, immune modulation, and chemoradiosensitization.

This study reports the pharmacokinetics and tissue distribution of 6βCHV in rats after oral administration, showing delayed absorption and wide tissue distribution.

This study evaluates the acute and 28-day repeat-dose toxicity of Vernolac in Wistar rats, finding no significant toxicity at up to four times the therapeutic dose.

This study evaluates the anti-cancer effects of Vernolac extract on NTERA-2 cl.D1 cancer stem-like cells, showing significant cytotoxicity and apoptosis induction with minimal impact on non-cancerous cells.

This study evaluates thymoquinone's anti-proliferative and pro-apoptotic effects on NTERA-2 cancer stem-like cells and PBMCs, showing dose- and time-dependent inhibition of proliferation and increased apoptosis.